Children over 4 years of age and adolescents
If you are unsure, talk to your doctor or pharmacist before taking omeprazole.
Warnings and precautions
Consult your doctor or pharmacist before starting to take omeprazole.
Severe skin reactions have been reported in relation to omeprazole treatment, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalized pustular psoriasis (AGPP). Stop taking omeprazole and consult your doctor immediately if you experience any of these symptoms related to severe skin reactions described in section 4.
Omeprazole may mask the symptoms of other diseases.Therefore, if you experience any of the following symptoms before starting to take omeprazole or during treatment, consult your doctor immediately:
If you take omeprazole for a long period (more than 1 year), your doctor will probably perform regular check-ups. Inform your doctor of any new or unusual symptoms and circumstances whenever you visit your doctor.
If you are taking proton pump inhibitors like omeprazole, especially for more than a year, you may slightly increase the risk of hip, wrist, and spinal fractures. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
If you experience a skin rash, especially in sun-exposed areas, consult your doctor as soon as possible, as it may be necessary to interrupt omeprazole treatment. Remember to mention any other symptoms you may notice, such as joint pain.
Omeprazole may cause kidney inflammation. Signs and symptoms may include decreased urine volume or blood in the urine and/or hypersensitivity reactions such as fever, skin rash, and joint stiffness. Inform your doctor of these signs.
This medicine may affect the way your body absorbs vitamin B12, especially if you need to take it for a long time. Contact your doctor if you notice any of the following symptoms, which may indicate low vitamin B12 levels:
Children
Some children with chronic diseases may require long-term treatment, although it is not recommended. Do not administer this medicine to children under 1 year of age or <10
Other medicines and Omeprazol Krka
Inform your doctor or pharmacist if you are using, have used recently, or may need to use other medicines.
Omeprazole may affect the mechanism of action of some medicines and some medicines may affect omeprazole.
Do not take omeprazole if you are taking a medicine that contains nelfinavir (used to treat HIV infection).
Inform your doctor or pharmacist if you are taking any of the following medicines:
If your doctor has prescribed you antibiotics amoxicillin and clarithromycin to treat ulcers caused by Helicobacter pylori infection, it is very important to inform your doctor of any other medicines you are taking.
Taking Omeprazol Krka with food and drinks
You can take your capsules with food or on an empty stomach.
Pregnancy and breastfeeding
Before taking omeprazole, inform your doctor if you are pregnant, think you may be pregnant, or plan to become pregnant. Your doctor will decide if you can take omeprazole during this time.
Your doctor will decide if you can take omeprazole if you are breastfeeding.
Driving and operating machines
Omeprazole is unlikely to affect your ability to drive or use tools or machines. However, side effects such as dizziness and visual disturbances (see section 4) may occur. If they do, you should not drive or use machines.
Omeprazol Krka contains saccharose
This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and age.
The recommended dose is described below.
Use in adults:
Treatment of symptoms of GERD, such asheartburn and acid regurgitation:
Treatment ofulcers of the upper part of the intestine(duodenal ulcer):
Treatment ofstomach ulcers(gastric ulcer):
Treatment ofulcers of the stomach and duodenum caused by NSAIDs(nonsteroidal anti-inflammatory drugs):
Prevention of stomach and duodenal ulcersduring the administration ofNSAIDs:
Treatment ofulcers causedby the infectionbyHelicobacter pyloriandprevention of their reappearance:
Treatment of excess acid in the stomach caused by atumor in the pancreas (Zollinger-Ellison syndrome):
Use in children and adolescents:
Treatment of symptoms of GERD, such asheartburn and acid regurgitation
Treatment ofulcerscausedby the infectionbyHelicobacter pyloriand prevention of their reappearance:
How to take this medication
What to do if you or your child have trouble swallowing the capsules
If you take more Omeprazol Krka than you should
If you have taken more omeprazole than prescribed by your doctor, consult your doctor or pharmacist immediately.You can also call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Omeprazol Krka
If you forget to take a dose, take it as soon as you remember. However, if there is little time left for the next dose, skip the missed dose. Do not take a double dose to make up for the missed doses.
If you have any other questions about the use of thismedication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you experience any of the following rare (may affect up to 1 in 1,000 people) or very rare (may affect up to 1 in 10,000 people) but serious side effects, stop taking Omeprazol Krka and consult your doctor immediately:
Other side effects are:
Frequent side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 1,000 people):
Very rare side effects(affect less than 1 in 10,000 patients):
Side effects of unknown frequency (Cannot be determined from available data):
In very rare cases, omeprazole may affect white blood cells in the blood and cause immunodeficiency. If you experience an infection with symptoms such as fever with a general state of deterioration or fever with symptoms of local infection, such as neck pain, throat pain, or mouth pain or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential to provide information about the medication you are taking at that time.
Do not worry about this list of possible side effects. You may not experience any of them. If you consider that any of the side effects you experience are severe or if you experience any side effect not mentioned in this prospectus, inform your doctor or pharmacist.
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use:www.notificaram.es.By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above30°C.
Store the blister pack in the original packaging to protect it from moisture.
Medicines should not be disposed of through drains or in the trash. Deposit the packaging and medicines you no longer need at theSIGREcollection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Omeprazol Krka
-The other components are: cornstarch and sucrose; sodium lauryl sulfate, disodium phosphate, mannitol, hypromellose, macrogol 6000, talc, poloxamer 80, titanium dioxide, methacrylic acid copolymer and ethyl acrylate copolymer.Components of the capsule: water, gelatin, titanium dioxide (E-171) andindigo carmine (E 132).
Appearance of the product and content of the packaging
The capsules are formed by an opaque white body and an opaque blue cap, containing spherical pellets with enteric coating, white to cream-colored.
Packaging sizes:
Blister packs of 14 and 28 capsules.
Only some packaging sizes may be commercially available.
Marketing Authorization Holder
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
Responsible for Manufacturing
Laboratorios Liconsa, S.A.,Avda. Miralcampo, Nº 7, Pol. Ind. Miralcampo,19200
Azuqueca de Henares (Guadalajara),
Spain
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10, 28108
Alcobendas, Madrid,
Spain
Last review date of this leaflet:May 2025
The detailed information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.